
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Articles |
Authors' Affiliation: University of Minnesota Cancer Center, Minneapolis, Minnesota
Requests for reprints: Fekadu Kassie, University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street Southeast, Minneapolis, MN 55455. Phone: 612-626-5143; Fax: 612-626-5135; E-mail: kassi012{at}umn.edu.
We have previously generated convincing evidence that combinations of N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine (PEITC-NAC; 3 µmol/g diet) and myo-inositol (MI; 56 µmol/g diet) were significantly more effective than the individual compounds as inhibitors of tobacco smoke carcinogen–induced lung tumorigenesis in A/J mice. In this study, we further investigated the efficacy of combinations of PEITC-NAC (9 or 15 µmol/g diet) and MI (56 µmol/g diet). Female A/J mice were treated with a mixture of the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene by gavage once weekly for 8 weeks. PEITC-NAC plus MI was given in the diet beginning at 1 day after the 4th of eight carcinogen treatments (temporal sequence A) or 1 week after the last carcinogen treatment (temporal sequence B). Regardless of the dose of carcinogen or PEITC-NAC plus MI, or temporal sequence, administration of PEITC-NAC plus MI significantly reduced the multiplicity of gross tumors and, in most instances, adenocarcinoma. PEITC-NAC plus MI was particularly effective against bigger tumors. The observed inhibition of lung tumorigenesis by PEITC-NAC plus MI was attributed, at least partly, to inhibition of cell proliferation and induction of apoptosis. These results clearly show the efficacy of PEITC-NAC plus MI in the prevention of tobacco carcinogen–induced lung adenocarcinoma in A/J mice and provide a basis for future evaluation of PEITC-NAC plus MI in clinical trials as a chemopreventive agent for current and former smokers.
Key Words: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone benzo[a]pyrene lung tumorigenesis chemoprevention N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine myo-inositol
This article has been cited by other articles:
![]() |
F. Kassie, S. Kalscheuer, I. Matise, L. Ma, T. Melkamu, P. Upadhyaya, and S. S. Hecht Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice Carcinogenesis, February 1, 2010; 31(2): 239 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Memmott and P. A. Dennis The Role of the Akt/mTOR Pathway in Tobacco Carcinogen-Induced Lung Tumorigenesis Clin. Cancer Res., January 1, 2010; 16(1): 4 - 10. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |